Adagio Medical Holdings Cash Flow Statement (2023-2024) | ADGM

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Operating Activities
Net Income -9.56M-5.91M-9.57M-7.42M-4.69M
Depreciation and Depletion 0.10M0.10M0.30M0.30M0.20M
Share-based Compensation 0.11M0.11M0.11M
Gains from Investment Securities 0.02M-0.04M0.08M-0.09M-4.97M
Asset Writedowns and Impairment 0.00M0.08M-0.04M-0.01M
Non-cash Items 0.07M0.48M0.07M
Cash from Operations -7.10M-6.74M-6.96M-6.40M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.01M0.01M0.01M
Depreciation & Amortization (CF) 0.10M0.13M0.33M0.26M0.32M
Change in Working Capital
Change in Receivables -0.00M-0.07M0.17M-0.01M
Change in Inventory 3.03M0.28M0.51M0.13M
Change in Account Payables 0.88M0.87M-0.36M
Change in Accured Expenses -0.22M0.68M-0.29M-0.65M
Other Working Capital Changes -1.33M-0.09M0.01M1.26M
Investing Activities
Capital Expenditures 0.02M0.16M0.17M0.58M
Cash from Investing Activities -0.02M-0.16M-0.17M-0.58M
Financing Activities
Cash from Financing Activities 6.58M9.57M5.07M
Additional items
Exchange Rate Effect -0.07M0.03M0.01M0.04M
Change in Cash -0.60M2.70M-2.04M-6.89M
Free Cash Flow -7.12M-6.90M-7.14M-6.98M
Net Cash Flow -0.54M2.67M-2.06M-6.98M